Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: A randomized trial

Pharmacotherapy

Volumn 32, Issue 10, 2012, Pages 871-879

  Verret, Lucie ^a   Couturier, Justine ^a   Rozon, Andréanne ^a   Saudrais Janecek, Sarah ^a   St Onge, Amélie ^a   Nguyen, Angela ^a   Basmadjian, Arsène ^a   Tremblay, Simon ^a   Brouillette, Denis ^a   De Denus, Simon ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Anticoagulation; Pharmacist; Quality of life; Self management; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEALTH PROGRAM; HEART ATRIUM FIBRILLATION; HEMATURIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PHARMACIST; PHYSICIAN; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TERTIARY HEALTH CARE; THROMBOEMBOLISM; TOTAL QUALITY MANAGEMENT; TREATMENT DURATION;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; EPISTAXIS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, SPECIAL; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PATIENT EDUCATION AS TOPIC; PHARMACISTS; QUALITY OF LIFE; QUEBEC; SELF ADMINISTRATION; SELF CARE; WARFARIN; YOUNG ADULT;

EID: 84867293256     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01116     Document Type: Article

References (24)

1. Bartholow M. Top 200 prescription drugs of 2010. Pharmacy Times web site. http://www.pharmacytimes.com/publications/issue/2012/July2012/Top-200-Drugs-of- 2011. Accessed July 26, 2012.
2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:160S-98S.
3. Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010;376:975-83.
4. Nieuwlaat R, Barker L, Kim YK, et al. Underuse of evidencebased warfarin dosing methods for atrial fibrillation patients. Thromb Res 2010;125:e128-31.
5. Oertel LB, Libby EN. Is patient self-testing a good thing? J Thromb Thrombolysis 2011;29:214-8.
6. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006;367: 404-11.
7. Menendez-Jandula B, Souto JC, Oliver A, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med 2005;142: 1-10.
8. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999;281: 145-50.
9. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000;356:97-102.
10. Gadisseur AP, Kaptein AA, Breukink-Engbers WG, van der Meer FJ, Rosendaal FR. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. J Thromb Haemost 2004;2:584-91.
11. Soliman Hamad MA, van Eekelen E, van Agt T, van Straten AH. Self-management program improves anticoagulation control and quality of life: a prospective randomized study. Eur J Cardiothorac Surg 2009;35:265-9.
12. McCahon D, Murray ET, Murray K, Holder RL, Fitzmaurice DA. Does self-management of oral anticoagulation therapy improve quality of life and anxiety? Fam Pract 2011;28:134-40.
13. Matchar DB, Jacobson A, Dolor R, et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med 2010;363:1608-20.
14. Bungard TJ, Gardner L, Archer SL, et al. Evaluation of a pharmacist-managed anticoagulation clinic: improving patient care. Open Med 2009;3:e16-21.
15. Garwood CL, Dumo P, Baringhaus SN, Laban KM. Quality of anticoagulation care in patients discharged from a pharmacistmanaged anticoagulation clinic after stabilization of warfarin therapy. Pharmacotherapy 2008;28:20-6.
16. Plesch W, van den Besselaar AM. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol 2009;31:20-5.
17. Torreiro EG, Fernandez EG, Rodriguez RM, Lopez CV, Nunez JB. Comparative study of accuracy and clinical agreement of the CoaguChek XS portable device versus standard laboratory practice in unexperienced patients. Thromb Haemost 2009;101:969-74.
18. Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother 2006;40:633-8.
19. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9.
20. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118:511-20.
21. Garcia-Alamino JM, Ward AM, Alonso-Coello P, et al. Selfmonitoring and self-management of oral anticoagulation. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD003839. DOI: 10.1002/14651858.CD003839.pub2.
22. Dolor RJ, Ruybalid RL, Uyeda L, et al. An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481-The Home INR Study (THINRS). J Thromb Thrombolysis 2010;30:263-75.
23. Ferrando F, Mira Y, Contreras MT, Aguado C, Aznar JA. Implementation of SintromacWeb(R), a new internet-based tool for oral anticoagulation therapy telecontrol: study on system consistency and patient satisfaction. Thromb Haemost 2010;103:1091-101.
24. Singer DE, Chang Y, Fang MC, et al. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation? The ATRIA study. Circ Cardiovasc Qual Outcomes 2009;2:297-304.